磁共振引导放射治疗期间的患者体验与焦虑评估
单中心研究纳入66例接受1.5T磁共振引导直线加速器放疗的患者,在治疗时提供舒缓视频内容。患者体验总体良好或中性,焦虑水平在首次治疗前最高、治疗后下降,状态-特质焦虑量表评分从治疗前33降至治疗后29。
要点
- 41%的患者在首次及后续治疗时选择观看舒缓视频内容。
- 状态-特质焦虑量表评分首次治疗前33(SD 9)vs 治疗后29(SD 7),效应量0.7,P<.001。
- 第三次至第五次治疗前32(SD 9)vs 治疗后31(SD 8),效应量0.4,P=.009。
核心结论
- 患者能够在磁共振引导放射治疗期间舒适地观看视频监视器,该设置可用于未来应用如生物反馈。
- 相当一部分少数患者偏好观看舒缓视频以在治疗期间分散注意力。
- 尽管患者体验总体极好,但仍报告了焦虑;焦虑水平在治疗前最高,治疗后下降。
研究设计与样本
- 单中心研究,嵌套于使用磁共振直线加速器的放射治疗多结局评估(MOMENTUM)队列。
- 2021年11月至2022年11月期间纳入66例患者,其中男性59例(89%)。
- 在首次治疗分次(M1)及第三次、第四次或第五次治疗分次(M2)使用问卷评估患者体验和焦虑(状态-特质焦虑量表,STAI)。
- 使用配对t检验检验显著差异,并使用效应量(ES)估计差异幅度。
主要发现
- 磁共振引导放射治疗最常用于前列腺癌(45例,68%),其次为胰腺病灶(8例,12%)。
- 在M1和M2,59例患者中有24例(41%)偏好观看舒缓视频内容。
- 1例患者在M1无法舒适地观看视频监视器。
- 患者体验总体为良好或中性;17%的患者报告刺痛感。
- M1前焦虑水平为高(16%)、中(18%)或低至无(67%)。
关键数值与推荐
- 在M1和M2,59例患者中有24例(41%)偏好观看舒缓视频内容。
- STAI评分M1前33(SD 9)vs M1后29(SD 7)(ES 0.7;P<.001)。
- STAI评分M2前32(SD 9)vs M2后31(SD 8)(ES 0.4;P=.009)。
- 17%的患者报告刺痛感。
- M1前焦虑水平为高(16%)、中(18%)或低至无(67%)。
临床怎么用
- 患者能够在磁共振引导放射治疗期间舒适地观看视频监视器。
- 该设置可用于未来应用,如生物反馈。
- 相当一部分少数患者偏好观看舒缓视频以在治疗期间分散注意力。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess patient experience and anxiety during magnetic resonance (MR)-guided radiation therapy (MRgRT) using a hybrid 1.5Tesla (T) MR-guided linear accelerator (MR-Linac) when offered calming video content. METHODS AND MATERIALS: A single-center study was conducted within the Multi-Outcome Evaluation of Radiation Therapy Using the MR-Linac (MOMENTUM) cohort. Patients were offered to watch calming video content on a video monitor during treatment. Questionnaires were used to assess patient experience (MR-Linac patient-reported experience) and anxiety (State-Trait Anxiety Inventory, STAI) at first treatment fraction (M1) and at third, fourth, or fifth treatment fraction (M2). Paired t tests were used to test for significant differences, and effect sizes (ESs) were used to estimate the magnitude of the difference. RESULTS: Between November 2021 and November 2022, 66 patients were included. The majority were men (n = 59, 89%). MRgRT was most frequently delivered to prostate cancer (n = 45, 68%) followed by a lesion in the pancreas (n = 8, 12%). At M1 and M2, 24 of 59 patients (41%) preferred to watch calming video content. One patient was not able to look at the video monitor comfortably at M1. Patient experience was generally favorable or neutral; tingling sensations were reported by 17% of patients. Anxiety levels were high (16%), moderate (18%), or low to none (67%) prior to M1. STAI scores were 33 (SD, 9) prior to M1 and 29 (SD, 7) after M1 (ES, 0.7; P < .001). STAI scores were 32 (SD, 9) prior to M2 and 31 (SD, 8) after M2 (ES, 0.4; P = .009). CONCLUSIONS: Patients were able to comfortably view the video monitor during MRgRT. Consequently, this setup could be used for future applications, such as biofeedback. A sizable minority of patients preferred to watch calming videos that distracted them during treatment. Although the patients' experience was overall excellent, anxiety was reported. Anxiety levels were highest prior to treatment and decreased after treatment.
引用
- Westerhoff JM, Borman PTS, Rutgers RHA, et al. On Patient Experience and Anxiety During Treatment With Magnetic Resonance-Guided Radiation Therapy. Adv Radiat Oncol. 2024. PMID: 39035171. doi:10.1016/j.adro.2024.101537
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。